Fexinidazole in Human African Trypanosomiasis Due to T. b. Rhodesiense

计划入组 45 人 · 首次发布于 2019 年 6 月 4 日

A Retrospective Analysis of Suramin Treatment for Stage 1 TBR

计划入组 345 人 · 首次发布于 2023 年 9 月 29 日

Efficacy and safety of fexinidazole in patients with Human African Trypanosomiasis (HAT) due to Trypanosoma brucei rhodesiense: a multicentre, open-label clinical trial

计划入组 50 人

Sleeping Beauty Transposed PBL(NCI)

Fexinidazole

C₁₂H₁₃N₃O₃S

NPD-0142

Alaunos Therapeutics

United States

Unum Group

United States

Sleepiz AG

Switzerland

First Oral Treatment for Deadly Rhodesiense Sleeping Sickness Now Available in Three African Countries

EMA Approves First Single-Dose Oral Treatment for African Sleeping Sickness

Repurposed Sleeping Sickness Drug Shows Promise for Ultra-Rare Bachmann-Bupp Syndrome